Celon Pharma Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.31	26.85	32.36	82.9	147.8
Short-Term Investments	0.6	48.24	82.18	81.72	79.76
Cash & Short-Term Investments	19.91	75.09	114.54	164.62	227.55
Cash Growth	-73.49%	-34.45%	-30.42%	-27.65%	417.27%
Accounts Receivable	41.23	39.26	32.79	27.11	24.67
Other Receivables	10.94	12.72	15.45	6.59	2.57
Total Trade Receivables	52.17	51.99	48.24	33.7	27.25
Inventory	26.11	30.17	26.41	38.39	23.38
Other Current Assets	4.08	3.18	0.56	0.87	0.53
Total Current Assets	102.26	160.43	189.75	237.58	278.7
Net Property, Plant & Equipment	303.76	311.66	333.8	341.59	329.21
Other Intangible Assets	15.69	8.15	14.97	21.83	29.17
Long-Term Investments	16.91	41.79	11.42	13.25	38.12
Other Long-Term Assets	18.84	21.77	19.37	28.52	31.94
Total Assets	457.46	543.8	569.31	642.76	707.14
Accounts Payable	20.64	15.68	10.71	18.31	12.68
Accrued Expenses	13.67	12.33	8.83	8.18	3.56
Current Portion of Long-Term Debt	1.61	1.53	12.75	0	0
Current Portion of Leases	7.16	7.14	7.13	19.43	6.56
Other Current Liabilities	20.18	30.22	46.92	70.52	7.73
Total Current Liabilities	63.27	66.9	86.34	116.44	86.36
Long-Term Debt	1.43	0	-	-	-
Long-Term Leases	8.74	8.26	5.71	7.39	8.35
Other Long-Term Liabilities	20.78	23.44	31.71	39.29	58.42
Total Long-Term Liabilities	30.95	31.69	37.42	46.68	66.77
Total Liabilities	94.21	98.59	123.75	163.12	153.14
Common Stock	5.39	5.39	5.11	5.1	5.1
Additional Paid-in Capital	520.05	554.5	544.91	1.62	614.82
Accumulated Other Comprehensive Income	-2.28	0.28	4.18	5.61	25.76
Retained Earnings	-319.81	-229.92	-108.64	-119.79	-91.67
Shareholders' Equity	363.25	445.21	445.56	479.65	554
Total Liabilities & Equity	457.46	543.8	569.31	642.76	707.14
Total Debt	18.94	16.93	25.59	26.82	14.92
Net Cash (Debt)	0.97	58.16	88.95	137.8	212.63
Net Cash Growth	-98.34%	-34.62%	-35.45%	-35.19%	1048.75%
Net Cash Per Share	0.02	1.08	1.74	2.70	4.55
Book Value	363.25	445.21	445.56	479.65	554
Book Value Per Share	6.84	8.27	8.73	9.40	11.87
Tangible Book Value	347.56	437.06	430.58	457.82	524.83
Tangible Book Value Per Share	6.54	8.12	8.44	8.97	11.24